EMA Authorised: Duaklir Genuair (aclidinium bromide;formoterol fumarate dihydrate) — Covis Pharma Europe B.V.

View source ↗

Summary

The European Medicines Agency authorised Duaklir Genuair, a fixed-dose inhaled combination of aclidinium bromide and formoterol fumarate for chronic obstructive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Duaklir Genuair (aclidinium bromide; formoterol fumarate dihydrate)

Snippet

Status: Authorised. Therapeutic area: Pulmonary Disease, Chronic Obstructive. MAH: Covis Pharma Europe B.V.. Decision date: 29/07/2025